The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to treat these conditions, current medications have several limitations, ...
Drugs that target opioid receptors sometimes have severe side effects. Thousands of people around the world die every day from overdoses involving opioids such as fentanyl. Researchers have taken a ...
Studies show that dual-NMR agonists provide strong analgesia across various pain types with a lower risk of physical dependence, tolerance, addiction, and respiratory depression, highlighting them as ...
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Saif Khan, USC Dornsife College of Letters, Arts and Sciences (THE CONVERSATION) ...
Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid (pronounced "mew-opioid") receptors. What they didn't know - until now - was ...
PVP Labs, a biotechnology company advancing next-generation peptide-based therapeutics, today announced its participation in the JP Morgan Healthcare Conference 2026, where the company will engage ...
(THE CONVERSATION) Naloxone, also known by the brand name Narcan, is one of the most important drugs in the United States’ fight against the opioid crisis. It reverses an opioid overdose nearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback